drugset / Trial / NCT01787344
Phase III Clinical Trial of "Botulax®" to Treat Children With Cerebral Palsy
RandomizedParallel-groupDouble-blindTreatment
Summary
To compare the safety and efficacy of Botulax Inj.®(Botulinum toxin type A, Hugel, South Korea) with Botox Inj.® (Botulinum toxin type A, Allergan, USA) in the treatment of cerebral palsy in children.
Timeline
- Start
- 2012-03
- Primary completion
- 2014-06
- Completion
- 2014-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Botulinum toxin type A | Protein / enzyme biologic | 4 iu/kg | — |
| Comparator | Botulinum toxin type A | Protein / enzyme biologic | 6 iu/kg | — |